Log in to save to my catalogue

Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10971204

Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

About this item

Full title

Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

Publisher

Switzerland: MDPI AG

Journal title

Journal of clinical medicine, 2024-03, Vol.13 (6), p.1546

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Surgery is the cornerstone of ovarian cancer treatment. However, surgery and perioperative inflammation have been described as potentially pro-metastagenic. In various animal models and other human cancers, intraoperative administration of non-steroidal anti-inflammatory drugs (NSAIDs) appears to have a positive impact on patient outcomes.
In th...

Alternative Titles

Full title

Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10971204

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10971204

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm13061546

How to access this item